From 1 January 2025, Chris H Boshoff will take over as Pfizer's new chief scientific officer. Previously he led its Cancer Research and Marketing.
Cancer is seen as the growth opportunity of the next ten years. Merck’s Keytruda is off patent in 2028, leaving the doors open for others.
Geoff Pain: the best, for those who want to know.
I’m not a scientist, but I can follow an argument.I dutifully read all the science-bits, and gratefully fall upon the “prose”.
Satanic Warp, not-so-speedy.
Thank you for all this information.
Cancer is seen as the growth opportunity of the next ten years. Merck’s Keytruda is off patent in 2028, leaving the doors open for others.
Geoff Pain: the best, for those who want to know.
I’m not a scientist, but I can follow an argument.I dutifully read all the science-bits, and gratefully fall upon the “prose”.
Satanic Warp, not-so-speedy.
Thank you for all this information.